Agilent Has Built an Annuity on Merck’s Clinical Programme, One Indication at a Time
Agilent won its eighth CE-marked companion diagnostic indication for a single PD-L1 assay, each one riding on a label expansion Merck paid to generate.
Deal Room
No post found!
No post found!
Access Watch
What’s Next
A Company Called StrokeDx Just Cleared a Device That Is Not Cleared to Detect Stroke
Dassault Paid $1.8B Cash for the Company That Processes 12 Million Safety Reports a Year
Trump Wants Generics Made in America by 2028. The Economics Say They Can’t.
